Biotech · Private company
Ocugenix Corporation
Track this companyFree. Adds Ocugenix Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- OCU-10-C-110 for InjectionPhase 1 · Neovascular Age-related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular DegenerationPHASE1 · ACTIVE_NOT_RECRUITING · started Nov 1, 2023ClinicalTrials.gov NCT05904691 · fetched Nov 12, 2026